Cannara Biotech (STU:8CB0) Dividends per Share : €0.00 (TTM As of Feb. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Dividends per Share?

Cannara Biotech's dividends per share for the three months ended in Feb. 2025 was €0.00. Its dividends per share for the trailing twelve months (TTM) ended in Feb. 2025 was €0.00. Its Dividend Payout Ratio for the three months ended in Feb. 2025 was 0.00. As of today, Cannara Biotech's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Cannara Biotech Dividends per Share Historical Data

The historical data trend for Cannara Biotech's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Dividends per Share Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Dividends per Share

Get a 7-Day Free Trial

Cannara Biotech Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Cannara Biotech's Dividends per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's Dividend Yield % falls into.

Save Embed

;

Save Embed

;

Cannara Biotech Dividends per Share Calculation

Dividends paid to per common share.

Cannara Biotech (STU:8CB0) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Cannara Biotech's Dividend Payout Ratio for the quarter that ended in Feb. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Feb. 2025 )	/	EPS without NRI (Q: Feb. 2025 )
	=	0	/	0.027
	=	0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Cannara Biotech Dividends per Share Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (STU:8CB0) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

LOVFF:USA LOVE:Canada

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

Cannara Biotech Headlines

No Headlines